Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs

Journal of the American Society of Nephrology

Volumn 16, Issue 1, 2005, Pages 269-277

  Chakkera, Harini A ^a,c   O'Hare, Ann M ^a   Johansen, Kirsten L ^a   Hynes, Denise ^b   Stroupe, Kevin ^a   Colin, Philip M ^a   Chertow, Glenn M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HINES VA HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HEALTH CARE SYSTEM; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; RECIPIENT; RISK FACTOR; VETERAN; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; ETHNOLOGY; GOVERNMENT; MIDDLE AGED; MORTALITY; STATISTICS; SURVIVAL; UNITED STATES;

ADULT; AFRICAN AMERICANS; COHORT STUDIES; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; SURVIVAL ANALYSIS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 21644442638     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004040333     Document Type: Article

References (40)

1. Cecka JM: The UNOS renal transplant registry. Clin Transpl 1-18, 2001
2. Zhou YC, Cecka JM, Terasaki PI: Effect of race on kidney transplants. Clin Transpl 447-459, 1990
3. Barger BO, Hudson SL, Shroyer TW, Deierhoi MH, Barber WH, Curtis JJ, Julian BA, Luke RG, Diethelm AG: Influence of race on renal allograft survival in the pre- and postcyclosporine era. Clin Transpl 217-233, 1987
4. Opelz G, Pfarr E, Engelmann A, Keppel E: Kidney graft survival rates in black cyclosporine-treated recipients. Collaborative Transplant Study. Transplant Proc 21: 3918-3920, 1989
5. Gaston RS, Shroyer TW, Hudson SL, Deierhoi MH, Laskow DA, Barber WH, Julian BA, Curtis JJ, Barger BO, Diethelm AG: Renal retransplantation: The role of race, quadruple immunosuppression, and the flow cytometry cross-match. Transplantation 57: 47-54, 1994
6. Gaston RS, Hudson SL, Deierhoi MH, Barber WH, Laskow DA, Julian BA, Curtis JJ, Barger BO, Shroyer TW, Diethelm AG: Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression. Transplantation 53: 103-109, 1992
7. Cosio FG, Dillon JJ, Falkenhain ME, Tesi RJ, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM: Racial differences in renal allograft survival: The role of systemic hypertension. Kidney Int 47: 1136-1141, 1995
8. Ngcobo TK, Becker P, Modiba MC: Effect of HLA-DR3 gene expression on cadaveric renal allograft survival in blacks. Clin Transpl 10: 60-62, 1996
9. Chertow GM, Milford EL: Poorer graft survival in African-American transplant recipients cannot be explained by HLA mismatching. Adv Ren Replace Ther 4: 40-45, 1997
10. Young CJ, Gaston RS: African Americans and renal transplantation: Disproportionate need, limited access, and impaired outcomes. Am J Med Sci 323: 94-99, 2002
11. Zhou YC, Cecka JM: Effect of HLA matching on renal transplant survival. Clin Transpl 499-510, 1993
12. Takemoto S, Cecka JM, Gjertson DW, Terasaki PI: Six-antigen-matched transplants. Causes of failure. Transplantation 55: 1005-1008, 1993
13. Akerley WL 3rd, Moritz TE, Ryan LS, Henderson WG, Zacharski LR: Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer. Arch Intern Med 153: 1681-1688, 1993
14. Bennett CL, Horner RD, Weinstein RA, Dickinson GM, DeHovitz JA, Cohn SE, Kessler HA, Jacobson J, Goetz MB, Simberkoff M: Racial differences in care among hospitalized patients with Pneumocystis carinii pneumonia in Chicago, New York, Los Angeles, Miami, and Raleigh-Durham. Arch Intern Med 155: 1586-1592, 1995
15. Dominitz JA, Samsa GP, Landsman P, Provenzale D: Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer 82: 2312-2320, 1998
16. Jha AK, Shlipak MG, Hosmer W, Frances CD, Browner WS: Racial differences in mortality among men hospitalized in the Veterans Affairs health care system. JAMA 285: 297-303, 2001
17. US General Accounting Office: Report to the Chairman, Committee on Veterans Affairs, House of Representatives. VA Health Care: Expanded Eligibility Has increased Outpatient Pharmacy Use and Expenditures, Washington, DC, US General Accounting Office, 2002 (GAO-03-161)
18. The Benefits Improvement and Protection Act of 2000, PL 106-554 §113
19. The Veterans Health Care Eligibility Reform Act of 1996, PL 104-262
20. Murphy PA, Cowper DC, Seppala G, Stroupe KT, Hynes DM: Veterans Health Administration inpatient and outpatient care data: An overview. Eff Clin Pract 5: E4, 2002
21. Hines EJ: The Medical SAS Inpatient Data Sets-FY 2000. A VIREC Resource Guide, Veterans Affairs Information Resource Center Hines, IL, 2000
22. Hines EJ: VIReC Research User Guide: FY 2002 VHA Medical SAS Inpatient Data Sets, Veterans Affairs Information Resource Center Hines, IL, 2002
23. Schreiner GE: How end-stage renal disease (ESRD)-Medicare developed. Am J Kidney Dis 35: S37-S44, 2000
24. Cox D: Regression models and life tables. J R Stat Soc 74: 187-220, 1972
25. Lin DY, Wei L: The robust inference for the Cox proportional hazards model. J Am Stat Assoc 84: 1074-1078, 1989
26. Scantlebury V, Gjertson D, Eliasziw M, Terasaki P, Fung J, Shapiro R, Donner A, Starzl TE: Effect of HLA mismatch in African-Americans. Transplantation 65: 586-588, 1998
27. Butkus DE, Meydrech EF, Raju SS: Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors. N Engl J Med 327: 840-845, 1992
28. Leffell MS, Steinberg AG, Bias WB, Machan CH, Zachary AA: The distribution of HLA antigens and phenotypes among donors and patients in the UNOS registry. Transplantation 58: 1119-1130, 1994
29. Lee TD, Lee A, Shi WX: HLA-A, -B, -DR, -DQ antigens in black North Americans. Tissue Antigens 37: 79-83, 1991
30. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Kahan BD: Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Transplantation 51: 338-342, 1991
31. Neylan JF: Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. Transplantation 65: 515-523, 1998
32. First MR, Schroeder TJ, Monaco AP, Simpson MA, Curtis JJ, Armenti VT: Cyclosporine bioavailability: Dosing implications and impact on clinical outcomes in select transplantation subpopulations. Clin Transpl 10: 55-59, 1996
33. Neylan JF: Immunosuppressive therapy in high-risk transplant patients: Dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 64: 1277-1282, 1997
34. Arozullah AM, Ferreira MR, Bennett RL, Gilman S, Henderson WG, Daley J, Khuri S, Bennett CL: Racial variation in the use of laparoscopic cholecystectomy in the Department of Veterans Affairs medical system. J Am Coll Surg 188: 604-622, 1999
35. Conigliaro J, Whittle J, Good CB, Hanusa BH, Passman LJ, Lofgren RP, Allman R, Ubel PA, O'Connor M, Macpherson DS: Understanding racial variation in the use of coronary revascularization procedures: The role of clinical factors. Arch Intern Med 160: 1329-1335, 2000
36. Oddone EZ, Horner RD, Diers T, Lipscomb J, McIntyre L, Cauffman C, Whittle J, Passman LJ, Kroupa L, Heaney R, Matchar D: Understanding racial variation in the use of carotid endarterectomy: The role of aversion to surgery. J Nat Med Assoc 90: 25-33, 1998
37. Washington DL, Harada ND, Villa VM, Damron-Rodriguez J, Dhanani S, Shon H, Makinodan T: Racial variations in Department of Veterans Affairs ambulatory care use and unmet health care needs. Mil Med 167: 235-241, 2002
38. Deswal A, Petersen NJ, Souchek J, Ashton CM, Wray NP: Impact of race on health care utilization and outcomes in veterans with congestive heart failure. J Am Coll Cardiol 43: 778-784, 2004
39. Freeman VL, Durazo-Arvizu R, Arozullah AM, Keys LC: Determinants of mortality following a diagnosis of prostate cancer in Veterans Affairs and private sector health care systems. Am J Public Health 93: 1706-1712, 2003
40. Heisler M, Smith DM, Hayward RA, Krein SL, Kerr EA: Racial disparities in diabetes care processes, outcomes, and treatment intensity. Med Care 41: 1221-1232, 2003